Form D — Traws Pharma, Inc.
0001130598-26-000004 · filed Nov 5, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $50,000,000
- Reported amount sold
- $0
- Minimum investment
- $0
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Traws Pharma, Inc.
- CIK
- 1130598
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 12 PENNS TRAIL
NEWTOWN, PA 18940 - Phone
- 267-759-3680
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Iain Dukes · Executive OfficerNewton, PA Find on LinkedIn ↗
-
Charles Parker · Executive OfficerNewton, PA Find on LinkedIn ↗
-
Jack E. Stover · DirectorNewtown, PA Find on LinkedIn ↗
-
Nikolay Savchuk · DirectorNewtown, PA Find on LinkedIn ↗
-
Trafford Clarke · DirectorNewtown, PA Find on LinkedIn ↗
-
Mary Teresa Shoemaker · DirectorNewtown, PA Find on LinkedIn ↗
-
John Leaman · DirectorNewtown, PA Find on LinkedIn ↗
-
Werner Cautreels · DirectorNewtown, PA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗